BRISTOL MYERS SQUIBB CO Logo

BRISTOL MYERS SQUIBB CO

Develops innovative medicines for oncology, immunology, and cardiovascular diseases.

BMY | NYSE

Overview

Corporate Details

ISIN(s):
US1101222073 (+1 more)
LEI:
Country:
United States of America
Address:
ROUTE 206 AND PROVINCE LINE ROAD, 8543 PRINCETON
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Bristol Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines to help patients prevail over serious diseases. The company's primary focus is on therapeutic areas with significant unmet medical needs, including oncology, hematology, immunology, and cardiovascular disease. Its operations encompass the full lifecycle of drug development, from scientific research and clinical trials to manufacturing, marketing, and distribution of its products worldwide. The company is committed to transforming patients' lives through scientific innovation.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all BRISTOL MYERS SQUIBB CO filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BRISTOL MYERS SQUIBB CO

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BRISTOL MYERS SQUIBB CO via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
ESSA Pharma Inc. Logo
Develops novel small molecule drugs to treat castration-resistant prostate cancer.
United States of America EPIX
Estrella Immunopharma, Inc. Logo
Clinical-stage biopharma developing ARTEMIS® T-cell therapies for cancer & autoimmune disease.
United States of America ESLA
Eton Pharmaceuticals, Inc. Logo
Develops and commercializes innovative treatments for rare pediatric diseases.
United States of America ETON
EuBiologics Co., Ltd. Logo
Develops vaccines for global public health and provides biopharmaceutical CRMO services.
South Korea 206650
EUPRAXIA PHARMACEUTICALS INC. Logo
Developing targeted, extended-release therapies for GI and musculoskeletal diseases.
United States of America EPRX
EuroAPI Logo
Global manufacturer of APIs and CDMO services for human and animal health partners worldwide.
France EAPI
Eurobio Scientific Logo
Develops & distributes specialty IVD tests for oncology, transplant & infectious diseases.
France ALERS
European Institute of Science AB Logo
Manufactures diagnostic assays and point-of-care instruments for the veterinary health market.
Sweden EURI B
Evoke Pharma Inc Logo
Develops and commercializes a nasal spray for diabetic gastroparesis symptom relief.
United States of America EVOK
Evolus, Inc. Logo
Develops neurotoxins and dermal fillers for the medical aesthetics market.
United States of America EOLS

Talk to a Data Expert

Have a question? We'll get back to you promptly.